Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Sirukumab> ?p ?o }
Showing triples 1 to 66 of
66
with 100 triples per page.
- Sirukumab abstract "Sirukumab (INN, USAN) (developmental code name CNTO-136) is a human monoclonal antibody designed for the treatment of rheumatoid arthritis. It acts against the proinflammatory cytokine Interleukin 6 (IL-6).Sirukumab is currently under development by Johnson & Johnson's subsidiary Centocor and has started clinical trials. and reported some phase II results.In December 2015 three phase III trials (SIRROUND-D, -H and -T) were collecting data.The drug is currently in phase II clinical trials for the treatment of depression.[1]".
- Sirukumab atcPrefix "none".
- Sirukumab casNumber "1194585-53-9".
- Sirukumab wikiPageExternalLink 800026523.
- Sirukumab wikiPageID "33024146".
- Sirukumab wikiPageLength "3303".
- Sirukumab wikiPageOutDegree "14".
- Sirukumab wikiPageRevisionID "707386520".
- Sirukumab wikiPageWikiLink Anti-IL-6.
- Sirukumab wikiPageWikiLink Category:Antidepressants.
- Sirukumab wikiPageWikiLink Category:Janssen_Biotech.
- Sirukumab wikiPageWikiLink Clinical_trial.
- Sirukumab wikiPageWikiLink Depression_(mood).
- Sirukumab wikiPageWikiLink Drug_development.
- Sirukumab wikiPageWikiLink Interleukin_6.
- Sirukumab wikiPageWikiLink International_nonproprietary_name.
- Sirukumab wikiPageWikiLink Janssen_Biotech.
- Sirukumab wikiPageWikiLink Johnson_&_Johnson.
- Sirukumab wikiPageWikiLink Phases_of_clinical_research.
- Sirukumab wikiPageWikiLink Rheumatoid_arthritis.
- Sirukumab wikiPageWikiLink United_States_Adopted_Name.
- Sirukumab wikiPageWikiLinkText "Sirukumab".
- Sirukumab wikiPageWikiLinkText "sirukumab".
- Sirukumab atcPrefix "none".
- Sirukumab c "6450".
- Sirukumab casNumber "1194585".
- Sirukumab chemspiderid "none".
- Sirukumab h "9926".
- Sirukumab mabType "mab".
- Sirukumab molecularWeight "144.6".
- Sirukumab n "1690".
- Sirukumab o "1998".
- Sirukumab s "46".
- Sirukumab source "u".
- Sirukumab target Interleukin_6.
- Sirukumab type "mab".
- Sirukumab verifiedfields "changed".
- Sirukumab verifiedrevid "464392155".
- Sirukumab wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Sirukumab wikiPageUsesTemplate Template:Cascite.
- Sirukumab wikiPageUsesTemplate Template:Chemspidercite.
- Sirukumab wikiPageUsesTemplate Template:Drugbankcite.
- Sirukumab wikiPageUsesTemplate Template:Drugbox.
- Sirukumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Sirukumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Sirukumab wikiPageUsesTemplate Template:Reflist.
- Sirukumab subject Category:Antidepressants.
- Sirukumab subject Category:Janssen_Biotech.
- Sirukumab hypernym Antibody.
- Sirukumab type ChemicalSubstance.
- Sirukumab type Company.
- Sirukumab type Drug.
- Sirukumab type Antibody.
- Sirukumab type Chemical.
- Sirukumab type Company.
- Sirukumab type Drug.
- Sirukumab type ChemicalObject.
- Sirukumab type Thing.
- Sirukumab type Q8386.
- Sirukumab comment "Sirukumab (INN, USAN) (developmental code name CNTO-136) is a human monoclonal antibody designed for the treatment of rheumatoid arthritis. It acts against the proinflammatory cytokine Interleukin 6 (IL-6).Sirukumab is currently under development by Johnson & Johnson's subsidiary Centocor and has started clinical trials.".
- Sirukumab label "Sirukumab".
- Sirukumab sameAs Q7530673.
- Sirukumab sameAs m.0h51yk9.
- Sirukumab sameAs Q7530673.
- Sirukumab wasDerivedFrom Sirukumab?oldid=707386520.
- Sirukumab isPrimaryTopicOf Sirukumab.